Primary Results with the New Hall-Kaster Disc Valve Prosthesis in Mitral Position

Summary

The Hall-Kaster central flow prosthetic heart valve was introduced in 1977 in an attempt to improve the hemodynamics of the disc valve prostheses. Towards this accomplishment, innovations in the tilting axis, the disc guidance mechanisms, and disc translatiónal freedom cooperate to improve flow through both orifice segments of the open valve. The present study reports on the primary clinical and hemodynamic findings in the first 20 patients (mean age 57,6 years) with isolated mitral valvular disease, examined 3–4 months after insertion of the Hall-Kaster disc valve prosthesis. The hemodynamic findings displayed low gradients and high calculated valve areas (5). At rest, the mean diastolic pressure gradient across the smallest prosthesis used (O.D. 27) averaged 3.0 mmHg, vs. 2.6 mmHg across the largest valve sizes (O.D. 29–31). Calculated valve area was on an average 3.08 cm² for the smaller valve, and 3.47 cm² for the larger valves, which corresponded to an utilization of 81 % and 77 % of the orifice area measured in vitro. A comparison with earlier studies of mean diastolic mitral gradients with different mitral prostheses indicates that the Hall-Kaster disc valve represents an improvement towards a hemodynamically more efficient prosthesis for mitral valve replacement.

Key-Words:

Hall-Kaster mitral disc valve prosthesis - Clinical and hemodynamic results